![Lipocine Inc](/common/images/company/N_LPCN.png)
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company product TLANDO is an oral testosterone replacement therapy TRT. It also has other produ... Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company product TLANDO is an oral testosterone replacement therapy TRT. It also has other products in the pipeline such as LPCN 1144 LPCN 1148 and LPCN 1107. Show more
Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal Study PR Newswire SALT LAKE CITY, June 25, 2024 Met standard bioequivalence (BE) criteria Cmax, AUC0-t, and...
Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024 PR Newswire SALT LAKE CITY, June 10, 2024 SALT LAKE CITY, June 10, 2024 /PRNewswire/...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.52 | -6.43564356436 | 8.08 | 8.7081 | 7.1717 | 31945 | 7.82071479 | CS |
4 | 0.56 | 8 | 7 | 11.79 | 6.27 | 91045 | 8.33045115 | CS |
12 | 1.8 | 31.25 | 5.76 | 11.79 | 4.38 | 90790 | 6.82119297 | CS |
26 | 4.65 | 159.793814433 | 2.91 | 11.79 | 2.82 | 58025 | 6.11493842 | CS |
52 | 2.46 | 48.2352941176 | 5.1 | 11.79 | 2.3101 | 75867 | 5.27675164 | CS |
156 | -17.6 | -69.9523052464 | 25.16 | 32.13 | 2.3101 | 312487 | 17.25855444 | CS |
260 | -24.74 | -76.5944272446 | 32.3 | 59.5 | 2.3101 | 986857 | 23.36907202 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.